End Diagnostic Overshadowing
NCT06608758
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this study is to address the critical issue of diagnostic overshadowing by applying the Collective Impact Model40 to co-produce our End Diagnostic Overshadowing program with academic, health systems, health professional, PWDs, family members, and community stakeholders. Through this work, we will identify and address mechanisms that contribute to diagnostic overshadowing and diagnostic errors among people with disabilities.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Disabilities Multiple
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 3 to 89 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Rush University Medical Center
- Last updated on ClinicalTrials.gov
- August 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Rush University Medical Center · Chicago, IL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.